Results of total pancreatectomy for adenocarcinoma of the pancreas Journal Article


Authors: Karpoff, H. M.; Klimstra, D. S.; Brennan, M. F.; Conlon, K. C.
Article Title: Results of total pancreatectomy for adenocarcinoma of the pancreas
Abstract: Hypothesis: Total pancreatectomy for infiltrating ductal adenocarcinoma is not superior to pancreaticoduodenectomy or distal pancreatectomy. Design: A retrospective analysis of a prospective database of patients. Setting: Memorial Sloan-Kettering Cancer Center, New York, NY. Patients: All patients (n=488) undergoing pancreatic resection. Main Outcome Measures: Duration of operation, estimated blood loss, complications, length of stay, number of positive lymph nodes, presence of a positive margin, and survival times were analyzed. Results: Thirty-five patients were identified who underwent total pancreatectomy, 28 of whom had adenocarcinoma. Median length of stay was 32 days; 19 (54%) developed postoperative complications, of which 63% were infectious. Thirty-day mortality was 3% (1 patient). Median survival was 9.3 months (range, 0.6-172 months). There was no significant difference between patients with and without adenocarcinoma in terms of duration of operation, estimated blood loss, complications, length of stay, or number of readmissions. In patients with adenocarcinoma, margin or nodal status were not significant survival variables. Patients undergoing total pancreatectomy for adenocarcinoma had a significantly worse overall survival than those undergoing total pancreatectomy for other reasons (P<.001), or compared with a contemporaneous cohort with adenocarcinoma undergoing pancreaticoduodenectomy (n=409) and distal pancreatectomy (n=51) (7.9 vs 17.2 months; P<.002). Conclusions: Total pancreatectomy can be performed safely with low mortality; survival is predicted by the underlying pathologic findings: patients undergoing total pancreatectomy for adenocarcinoma have a uniformly poor outcome. Those undergoing total pancreatectomy for benign disease or nonadenocarcinoma variants can have long-term survival. In patients who require total pancreatectomy for ductal adenocarcinoma, the survival is so poor as to bring into question the value of the operation.
Keywords: adult; cancer survival; clinical article; treatment outcome; middle aged; survival analysis; retrospective studies; cancer recurrence; pancreas resection; pancreatic neoplasms; prospective studies; adenocarcinoma; pancreas carcinoma; postoperative complication; postoperative complications; length of stay; pancreas adenocarcinoma; pancreatectomy; databases, factual; pancreas surgery; humans; human; male; female; priority journal; article
Journal Title: Archives of Surgery
Volume: 136
Issue: 1
ISSN: 0004-0010
Publisher: American Medical Association  
Date Published: 2001-01-01
Start Page: 44
End Page: 48
Language: English
PUBMED: 11146775
PROVIDER: scopus
DOI: 10.1001/archsurg.136.1.44
DOI/URL:
Notes: Export Date: 21 May 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Murray F Brennan
    1059 Brennan
  2. Howard M Karpoff
    16 Karpoff
  3. Kevin C Conlon
    120 Conlon
  4. David S Klimstra
    978 Klimstra